Having stripped back its workforce, antibiotics biotech Spero Therapeutics continues to strip away its remaining pipeline. | ...

By the time a doctor prescribes antibiotics, the microbial enemy has already slipped past our defenses. But the war against ...

Today, antibiotics are the third largest-selling ... manufactured by Micrologix Biotech (Vancouver, BC). The two-part phase II trials are intended to assess the safety, pharmacokinetics, and ...

The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...

This antibiotic is the first new FDA-approved medication for urinary tract infections in decades, and meets the need for new ...

A study shows continued increase in antibiotic resistance is not inevitable and offers new insights to help monitor drug ...

While most pharma companies have exited the antibiotics area, Japanese drugmaker Shionogi has stuck with it and has just expanded its pipeline with a deal to buy US biotech Qpex Biopharma.

Researchers discover a new class of antibiotic that selectively targets Neisseria gonorrhoeae, the bacterium that causes gonorrhoea. These substances trigger a self-destruction program ...

In seeking new antibiotic sources, researchers have turned to an unlikely source: a whiffy frog known as Odorrana andersonii.

The novel antibiotic class could be active against the vast majority of multidrug-resistant Enterobacterales infections.

GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...